Author: biopronet – Page 2
Innovate UK – Transforming Medicines Manufacturing, Competition Winners
The Transforming Medicines Manufacturing team at Innovate UK are happy to announce the winners of the latest round of competitions in:
- Nucleic Acid Medicines Manufacturing
- Intracellular Drug Delivery
- Digitalisation and Automation of Medicines Manufacturing
£13 million to help transform medicines manufacturing – UKRI [ukri.org]
#InnovateUK #transformingmedicinesmanufacturing
20th Anniversary bioProcessUK Conference, Brighton 28-20 November
If you are successful, you get to attend the bioProcessUK conference in Brighton on 28-30 November 2023 free of charge! The deadline for applications is Friday 13 October 2023. Please email your entry to the events team at biaevents@bioindustry.org. Judging will be done by conference delegates and the overall winner will be awarded a prize.
|
Frontiers Retreat Brussels, October 2023
These meetings are dedicated to Early Career Scientists (ECSs) working in the advancing cell technology and related fields. We aim to continue engaging the next generation of ESACT scientists and to encourage those who have not attended previous ESACT meetings to actively participate in this community.
Frontiers Retreats are not classical meetings: they are built on a range of sessions focussed on career and personal development, stimulation of alternative thinking emerging from interaction with peers across a broad range of subject areas and level of experience, and promoting active networking among all participants. They also aim to stimulate scientific discussions and help to bridge the gap between industry and academia.
The Scientific Sessions are an amazing opportunity for ECSs to present their work, with most of the oral presentation slots being reserved for the ECSs selected from the high-quality abstracts submitted. There are also two very engaging poster sessions and there are prizes for both the best oral presentation and the best poster presentation.
The Career and Personal Development Sessions will help you to develop transferrable skills and extend your professional network. Few things are as important for an ECS: take this opportunity build upon your skills and network!
This meeting is open to the entire community, including non-ESACT members.
So, submit your abstract and save the date: 18th – 21st of October 2023.
Exciting opportunity within the BioPharmaceutical Development (BPD) department at AstraZeneca.
The BPD department, which focuses on creating novel products that fight disease and transform quality of life, has a two-year Rotational Associate Programme that consists ofthree eight-month rotational assignments across various BPD functions.
The programme enables recent graduates to make a difference by working on challenging technical projects supporting the development of protein therapeutics in the areas of Cell Culture and Fermentation, Purification, Analytics and Protein Characterisation, Formulation, Delivery Devices, Clinical Logistics and Manufacturing.
The programme is designed to equip participants with an understanding of each BPD function’s role in the drug development process, enable them to grow professionally and ensures a full-time position in BPD at the end of all three rotations.
They are looking for scientists with a focus on biology, chemistry, biochemistry, engineering or related discipline (Bachelors and/or Master graduates with 0-2 years prior work experience).
Individuals should have strong academic performance, strong technical and lab skills, be critical thinkers, have good communication skills and a collaborative working style. Candidates should have a passion for science and a strong interest in a career in drug development.
Applications will be accepted from 22nd August for a start in 2024 f 2024. Applications for the programme will close in the UK on 8th October 2023.
Links and further information on the BPD Department and RAP program below –
https://careers.astrazeneca.com/bpd [careers.astrazeneca.com]
https://careers.astrazeneca.com/rap [careers.astrazeneca.com]
